[{"address1": "149 Fifth Avenue", "address2": "Suite 500", "city": "New York", "state": "NY", "zip": "10010", "country": "United States", "phone": "212 994 8200", "website": "https://www.protagenic.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "As of May 16, 2025, Protagenic Therapeutics, Inc. was acquired by Phytanix Bio, Inc., in a reverse merger transaction. Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 1, "companyOfficers": [], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.74, "open": 3.74, "dayLow": 3.45, "dayHigh": 3.7899, "regularMarketPreviousClose": 3.74, "regularMarketOpen": 3.74, "regularMarketDayLow": 3.45, "regularMarketDayHigh": 3.7899, "payoutRatio": 0.0, "beta": 0.377, "forwardPE": -6.362069, "volume": 210462, "regularMarketVolume": 210462, "averageVolume": 1927729, "averageVolume10days": 222130, "averageDailyVolume10Day": 222130, "bid": 0.0, "ask": 3.96, "bidSize": 0, "askSize": 40, "marketCap": 3204447, "fiftyTwoWeekLow": 2.35, "fiftyTwoWeekHigh": 15.54, "fiftyDayAverage": 3.83618, "twoHundredDayAverage": 5.677745, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1276755, "profitMargins": 0.0, "floatShares": 491613, "sharesOutstanding": 868414, "sharesShort": 32665, "sharesShortPriorMonth": 131495, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0376, "heldPercentInsiders": 0.1121, "heldPercentInstitutions": 0.047519997, "shortRatio": 0.01, "shortPercentOfFloat": 0.040700004, "impliedSharesOutstanding": 868414, "bookValue": -0.164, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -5241055, "trailingEps": -13.13, "forwardEps": -0.58, "lastSplitFactor": "1:14", "lastSplitDate": 1746403200, "enterpriseToEbitda": -0.238, "52WeekChange": -0.64857143, "SandP52WeekChange": 0.1116153, "quoteType": "EQUITY", "currentPrice": 3.69, "recommendationKey": "none", "totalCash": 872960, "totalCashPerShare": 1.482, "ebitda": -5360413, "totalDebt": 0, "quickRatio": 0.811, "currentRatio": 0.862, "returnOnAssets": -1.89599, "returnOnEquity": -5.1278996, "freeCashflow": -1714447, "operatingCashflow": -3625349, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PTIX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.3369, "regularMarketPrice": 3.69, "shortName": "Protagenic Therapeutics, Inc.", "longName": "Protagenic Therapeutics, Inc.", "postMarketChangePercent": 0.0, "postMarketPrice": 3.69, "postMarketChange": 0.0, "regularMarketChange": -0.05, "regularMarketDayRange": "3.45 - 3.7899", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1927729, "fiftyTwoWeekLowChange": 1.3400002, "fiftyTwoWeekLowChangePercent": 0.57021284, "fiftyTwoWeekRange": "2.35 - 15.54", "fiftyTwoWeekHighChange": -11.85, "fiftyTwoWeekHighChangePercent": -0.76254827, "fiftyTwoWeekChangePercent": -64.85714, "dividendDate": 1469577600, "earningsTimestamp": 1747133940, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755547200, "earningsCallTimestampStart": 1712003400, "earningsCallTimestampEnd": 1712003400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -13.13, "epsForward": -0.58, "fiftyDayAverageChange": -0.14617991, "fiftyDayAverageChangePercent": -0.038105592, "twoHundredDayAverageChange": -1.9877448, "twoHundredDayAverageChangePercent": -0.35009408, "priceToBook": -22.5, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-04-27", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1752277870, "regularMarketTime": 1752264000, "exchange": "NCM", "messageBoardId": "finmb_1886236531", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1619530200000, "displayName": "Protagenic Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-12"}]